HALEOS LABS
Back to Balance Sheet
|
HALEOS LABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹19 Cr | ₹18 Cr | ₹4.81 Cr | ₹5.44 Cr | ₹7.20 Cr |
What is the latest Contingent Liabilities ratio of HALEOS LABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹19 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹4.81 Cr |
| Mar2022 | ₹5.44 Cr |
| Mar2021 | ₹7.20 Cr |
How is Contingent Liabilities of HALEOS LABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹19 Cr | 3.53 | |
| Mar2024 | ₹18 Cr | 276.18 | |
| Mar2023 | ₹4.81 Cr | -11.53 | |
| Mar2022 | ₹5.44 Cr | -24.47 | |
| Mar2021 | ₹7.20 Cr | - | |
Compare Contingent Liabilities of peers of HALEOS LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HALEOS LABS | ₹474.9 Cr | 2.4% | 9.2% | 20.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
HALEOS LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HALEOS LABS | 2.4% |
9.2% |
20.5% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses